SCHEMBL4165147

SCHEMBL4165147

NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)N(C(=O)Cc1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 7/20 0.43
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
MC4R P32245 1/20 0.33
MC3R P41968 1/20 0.33
PLAU P00749 1/20 0.32
UTS2R Q9UKP6 2/20 0.32
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
PLA2G4B P0C869 1/20 0.31
FAAH O00519 4/20 0.31
CES2 O00748 2/20 0.31
PLA2G6 O60733 1/20 0.31
PTGES O14684 1/20 0.30
ALOX5 P09917 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606140 0.91 CES1 (0.35) CES1HDAC1HDAC2MC4RMC3R
SCHEMBL4154197 0.87 HDAC1 (0.37) CES1HDAC1HDAC2LMNA
SCHEMBL4171428 0.86 CES1 (0.44) CES1HDAC1HDAC2FAAHCES2
SCHEMBL4158069 0.77 CES1 (0.46) CES1HDAC1HDAC2FAAHCES2
SCHEMBL4173034 0.75 CES1 (0.33) CES1HDAC1HDAC2
SCHEMBL4166891 0.74 CES1 (0.52) CES1HDAC1HDAC2
SCHEMBL4162820 0.74 CES1 (0.42) CES1HDAC1HDAC2ALOX5ALDH1A1
SCHEMBL4164042 0.73 CES1 (0.37) CES1HDAC1HDAC2LMNA
SCHEMBL4160414 0.73 CES1 (0.35) CES1HDAC1HDAC2ALOX5LMNA
Trifluoroacetic Acid SCHEMBL4304780 0.73 CES1 (0.50) CES1HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CES1 1925/4885HDAC1 2/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.